NCT05748600

Brief Summary

The purpose of this study is to evaluate dexpramipexole as an add-on oral therapy in participants with inadequately controlled eosinophilic asthma to evaluate improvements in lung function, asthma control, and quality of life. In addition, the study will further evaluate the safety and tolerability of dexpramipexole in participants with eosinophilic asthma.

Trial Health

67
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Strong global presence with extensive site network
Enrollment
600

participants targeted

Target at P75+ for phase_3

Timeline
Completed

Started Jan 2023

Typical duration for phase_3

Geographic Reach
18 countries

335 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 30, 2023

Completed
21 days until next milestone

First Submitted

Initial submission to the registry

February 20, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 28, 2023

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

September 5, 2025

Status Verified

August 1, 2025

Enrollment Period

2.6 years

First QC Date

February 20, 2023

Last Update Submit

August 29, 2025

Conditions

Keywords

FEV1AsthmaDexpramipexoleEXHALEEXHALE-4AreteiaUncontrolled AsthmaAsthma Attackforced expiratory volume

Outcome Measures

Primary Outcomes (1)

  • Change in pre-BD FEV₁ from baseline

    Pre-bronchodilator forced expiratory volume (pre-BD) FEV₁, absolute change from baseline, averaged over Weeks 20 and 24.

    Day 1 (baseline, pre-dose), Weeks 20, 24

Secondary Outcomes (7)

  • Change from baseline in Asthma Control Questionnaire-6 (ACQ-6)

    Day 1 (baseline, pre-dose), Weeks 20, 24

  • Change in Standardized version of the Asthma Quality of Life Questionnaire for 12 years and older (AQLQ+12) from baseline to Week 24.

    Day 1 (baseline, pre-dose) through Week 24

  • Change from baseline absolute eosinophil count (AEC) averaged across Weeks 20 and 24.

    Day 1 (baseline, pre-dose) through Week 24

  • Change from baseline forced vital capacity (FVC) averaged over Weeks 20 and 24.

    Day 1 (baseline, pre-dose), Weeks 20, 24

  • Change from baseline forced vital capacity (FVC) at Weeks 4, 8, 12, 16, 20, and 24.

    Day 1 (baseline, pre-dose), Weeks 4, 8, 12, 16, 20, and 24

  • +2 more secondary outcomes

Study Arms (3)

150 mg BID

EXPERIMENTAL

Dexpramipexole 150 mg oral tablet taken twice a day

Drug: Dexpramipexole Dihydrochloride

75 mg BID

EXPERIMENTAL

Dexpramipexole 75 mg oral tablet taken twice a day

Drug: Dexpramipexole Dihydrochloride

Placebo

PLACEBO COMPARATOR

Placebo oral tablet taken twice a day

Drug: Placebo

Interventions

administration of dexpramipexole tablet

150 mg BID75 mg BID

administration of placebo tablet

Placebo

Eligibility Criteria

Age12 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Signed informed consent form and assent form, as appropriate.
  • Male or female ≥12 years of age at Screening Visit 1. Sites in Poland will only include participants aged ≥18 years.
  • Asthma-related criteria
  • Documented physician diagnosis of asthma for ≥12 months prior to Screening Visit 1.
  • Participants requiring at a minimum daily low dose inhaled corticosteroids (ICS; ≥100 μg/day fluticasone propionate dry powder formulation daily or clinically comparable, per GINA 2021), plus one or more additional daily maintenance asthma controller medications, eg, long-acting β2 agonist (LABA), leukotriene antagonist, theophylline, long-acting muscarinic antagonists, cromolyn/nedocromil. Note: In Poland, this will instead include participants requiring a minimum daily medium dose ICS (≥500 μg/day fluticasone propionate dry powder formulation daily or clinically comparable, per GINA 2021). Use of daily ICS must be for at least 12 weeks prior to Screening Visit 1 and the doses of all controller medications must be stable for at least 4 weeks prior to Screening Visit 1.
  • Pre-BD FEV1 ≥40% and \<80% (\<90% for participants 12 to 17 years of age) of predicted at Screening Visit 2.
  • ACQ-6 ≥1.5 at Screening Visit 2.
  • Eosinophil count of ≥0.30x10⁹/L at Screening Visit 1. If the initial value is between 0.250x10⁹/L to 0.299x10⁹/L, then this may be repeated once at an unscheduled visit (prior to Screening Visit 2).
  • General medical history
  • Negative urine pregnancy test for women of childbearing potential (WOCBP; after menarche) at the Screening and Baseline visits.
  • WOCBP must use either of the following methods of birth control, from Screening Visit 1 through the End of Study Visit:
  • A highly effective form of birth control (confirmed by the investigator). Highly effective forms of birth control include: true sexual abstinence, a vasectomized sexual partner, Implanon, female sterilization by tubal occlusion, any effective intrauterine device (IUD), IUD/intrauterine system (IUS), Levonorgestrel Intrauterine system, or oral contraceptive.
  • Two protocol acceptable methods of contraception in tandem.
  • Women not of childbearing potential are defined as women who are either permanently sterilized (hysterectomy, bilateral oophorectomy, or bilateral salpingectomy), or who are postmenopausal. Women will be considered postmenopausal if they have been amenorrheic for 12 months prior to the planned date of the Baseline Visit without an alternative medical cause. The following age specific requirements apply:
  • Women \<50 years old will be considered postmenopausal if they have been amenorrheic for 12 months or more following cessation of exogenous hormonal treatment and follicle stimulating hormone levels in the postmenopausal range.
  • +1 more criteria

You may not qualify if:

  • Asthma-related criteria
  • A participant who experiences a severe asthma exacerbation (defined as a deterioration of asthma that results in emergency treatment, hospitalization prior to the Screening Visit 1 up to and including the Baseline Visit.
  • Participants who experience an asthma exacerbation during the Screening/Run-in Period may remain in screening and proceed with study visits 14 days after they have completed their course of oral steroids or returned to their pre-Screening visit maintenance dose of oral steroids and the investigator considers participant has returned to baseline status.
  • Current diagnosis of diseases which may confound interpretation of this study's findings such as allergic bronchopulmonary aspergillosis, eosinophilic granulomatosis with polyangiitis, eosinophilic gastrointestinal diseases, or hypereosinophilic syndrome, or lung diseases (eg, chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis).
  • Respiratory infection: Upper or lower respiratory tract, sinus, or middle ear infection within the 4 weeks before Screening Visit 1.
  • Prohibited medications/procedures
  • Treatment with a biologic investigational drug in the last 5 months prior to Screening Visit 1. Treatment with non-biologic investigational drugs in the previous 30 days or five-half-lives prior to Screening Visit 1, whichever is longer. Treatment with GSK3511294 (long acting anti-interleukin-5) in the past 12 months.
  • Treatment with any of the following monoclonal antibody therapies within 120 days prior to Baseline: benralizumab, dupilumab, mepolizumab, reslizumab, omalizumab, tezepelumab, or tralokinumab.
  • Treatment with pramipexole (Mirapex®) within 30 days of Baseline.
  • Treatment with selected drugs known to have a substantial risk of neutropenia in the past 30 days prior to Screening Visit 1.
  • Bronchial thermoplasty procedure in the past 12 months prior to Screening Visit 1 or planned during the study period.
  • General medical history
  • Weight \<40 kg at Screening Visit 2.
  • Current smoking within 12 months prior to Screening Visit 1 or a smoking history of \>10 packyears. Smoking includes tobacco, vaping, and/or marijuana use.
  • Known or suspected alcohol or drug abuse.
  • +22 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (335)

Research Site 40001-487

Chandler, Arizona, 85224, United States

Location

Research Site 40001-462

Peoria, Arizona, 85381, United States

Location

Research Site 40001-322

Surprise, Arizona, 85378, United States

Location

Research Site 40001-374

Bakersfield, California, 93301, United States

Location

Research Site 40001-227

Encinitas, California, 92024, United States

Location

Research Site 40001-349

Huntington Beach, California, 92647, United States

Location

Research Site 40001-485

Inglewood, California, 06410, United States

Location

Research Site 40001-440

La Palma, California, 90623, United States

Location

Research Site 40001-357

Lancaster, California, 93534, United States

Location

Research Site 40001-089

Los Angeles, California, 90048, United States

Location

Research Site 40001-362

Mission Viejo, California, 92691, United States

Location

Research Site 40001-449

Napa, California, 94558, United States

Location

Research Site 40001-062

Newport Beach, California, 92660, United States

Location

Research Site 40001-043

Newport Beach, California, 92663, United States

Location

Research Site 40001-380

Redding, California, 96001, United States

Location

Research Site 40001-434

San Diego, California, 92123, United States

Location

Research Site 40001-088

San Jose, California, 95117, United States

Location

Research Site 40001-359

Upland, California, 91756, United States

Location

Research Site 40001-003

West Covina, California, 91790, United States

Location

Research Site 40001-419

Westminster, California, 92683, United States

Location

Research Site 40001-425

Aurora, Colorado, 80014, United States

Location

Research Site 40001-353

Colorado Springs, Colorado, 80907, United States

Location

Research Site 40001-385

Wheat Ridge, Colorado, 80033, United States

Location

Research Site 40001-048

Aventura, Florida, 33180, United States

Location

Research Site 40001-005

Brandon, Florida, 33511, United States

Location

Research Site 40001-051

Brandon, Florida, 33511, United States

Location

Research Site 40001-029

Coral Gables, Florida, 33134, United States

Location

Research Site 40001-350

Gainesville, Florida, 32607, United States

Location

Research Site 40001-014

Greenacres City, Florida, 33467, United States

Location

Research Site 40001-054

Hialeah, Florida, 33012, United States

Location

Research Site 40001-067

Hialeah, Florida, 33016, United States

Location

Research Site 40001-020

Homestead, Florida, 33030, United States

Location

Research Site 40001-015

Kissimmee, Florida, 34744, United States

Location

Research Site 40001-002

Kissimmee, Florida, 34746, United States

Location

Research Site 40001-086

Loxahatchee Groves, Florida, 33470, United States

Location

Research Site 40001-318

Maitland, Florida, 32751, United States

Location

Research Site 40001-066

Miami, Florida, 33126, United States

Location

Research Site 40001-001

Miami, Florida, 33135, United States

Location

Research Site 40001-059

Miami, Florida, 33144, United States

Location

Research Site 40001-026

Miami, Florida, 33155, United States

Location

Research Site 40001-288

Miami, Florida, 33165, United States

Location

Research Site 40001-065

Miami, Florida, 33173, United States

Location

Research Site 40001-024

Miami, Florida, 33184, United States

Location

Research Site 40001-338

Miami Beach, Florida, 33169, United States

Location

Research Site 40001-348

Ocala, Florida, 34471, United States

Location

Research Site 40001-293

Orlando, Florida, 32819, United States

Location

Research Site 40001-429

Plantation, Florida, 33317, United States

Location

Research Site 40001-351

Sarasota, Florida, 34239, United States

Location

Research Site 40001-069

St. Petersburg, Florida, 33713, United States

Location

Research Site 40001-370

Tallahassee, Florida, 32308, United States

Location

Research Site 40001-004

Tampa, Florida, 33607, United States

Location

Research Site 40001-319

Viera, Florida, 32940, United States

Location

Research Site 40001-142

Adairsville, Georgia, 30103, United States

Location

Research Site 40001-075

Augusta, Georgia, 30909, United States

Location

Research Site 40001-018

Columbus, Georgia, 31904, United States

Location

Research Site 40001-452

Dunwoody, Georgia, 30350, United States

Location

Research Site 40001-483

East Point, Georgia, 30344, United States

Location

Research Site 40001-366

Lilburn, Georgia, 30047, United States

Location

Research Site 40001-423

Savannah, Georgia, 31406, United States

Location

Research Site 40001-090

Berwyn, Illinois, 60402, United States

Location

Research Site 40001-343

Chicago, Illinois, 60607, United States

Location

Research Site 40001-358

Normal, Illinois, 61761, United States

Location

Research Site 40001-135

River Forest, Illinois, 60305, United States

Location

Research Site 40001-403

Skokie, Illinois, 60077, United States

Location

Research Site 40001-036

Elwood, Indiana, 46036, United States

Location

Research Site 40001-347

Louisville, Kentucky, 40202, United States

Location

Research Site 40001-019

Owensboro, Kentucky, 42301, United States

Location

Research Site 40001-437

Alexandria, Louisiana, 71303, United States

Location

Research Site 40001-313

Marrero, Louisiana, 70072, United States

Location

Research Site 40001-352

Zachary, Louisiana, 70791, United States

Location

Research Site 40001-417

Annapolis, Maryland, 21401, United States

Location

Research Site 40001-466

Baltimore, Maryland, 21237, United States

Location

Research Site 40001-456

Takoma Park, Maryland, 20912, United States

Location

Research Site 40001-055

White Marsh, Maryland, 21162, United States

Location

Research Site 40001-468

Fall River, Massachusetts, 02723, United States

Location

Research Site 40001-427

Dearborn, Michigan, 48126, United States

Location

Research Site 40001-006

Flint, Michigan, 48504, United States

Location

Research Site 40001-148

Flint, Michigan, 48507, United States

Location

Research Site 40001-463

Rochester Hills, Michigan, 48307, United States

Location

Research Site 40001-442

Southfield, Michigan, 48034, United States

Location

Research Site 40001-372

Warren, Michigan, 48088, United States

Location

Research Site 40001-421

Mankato, Minnesota, 56001, United States

Location

Research Site 40001-083

Columbia, Missouri, 65203, United States

Location

Research Site 40001-074

Saint Charles, Missouri, 63301, United States

Location

Research Site 40001-046

St Louis, Missouri, 63110, United States

Location

Research Site 40001-409

Missoula, Montana, 59808, United States

Location

Research Site 40001-448

Lincoln, Nebraska, 68510, United States

Location

Research Site 40001-404

Omaha, Nebraska, 68798, United States

Location

Research Site 40001-473

Las Vegas, Nevada, 89109, United States

Location

Research Site 40001-387

Brick, New Jersey, 08724, United States

Location

Research Site 40001-363

Edison, New Jersey, 08817, United States

Location

Research Site 40001-457

Jersey City, New Jersey, 07304, United States

Location

Research Site 40001-355

Toms River, New Jersey, 08755, United States

Location

Research Site 40001-050

East Amherst, New York, 14051, United States

Location

Research Site 40001-412

Great Neck, New York, 11021, United States

Location

Research Site 40001-047

Hawthorne, New York, 10532, United States

Location

Research Site 40001-455

New York, New York, 10016, United States

Location

Research Site 40001-369

New York, New York, 10029, United States

Location

Research Site 40001-408

Charlotte, North Carolina, 28273, United States

Location

Research Site 40001-398

Charlotte, North Carolina, 28277, United States

Location

Research Site 40001-039

Gastonia, North Carolina, 28054, United States

Location

Research Site 40001-435

Greenville, North Carolina, 17834, United States

Location

Research Site 40001-111

Huntersville, North Carolina, 28078, United States

Location

Research Site 40001-382

Raleigh, North Carolina, 27610, United States

Location

Research Site 40001-439

Rocky Mount, North Carolina, 27804, United States

Location

Research Site 40001-283

Winston-Salem, North Carolina, 21704, United States

Location

Research Site 40001-034

Cincinnati, Ohio, 45215, United States

Location

Research Site 40001-013

Cincinnati, Ohio, 45219, United States

Location

Research Site 40001-010

Cincinnati, Ohio, 45236, United States

Location

Research Site 40001-413

Cleveland, Ohio, 44106, United States

Location

Research Site 40001-017

Dayton, Ohio, 45424, United States

Location

Research Site 40001-063

Toledo, Ohio, 43617, United States

Location

Research Site US-40001-038

Edmond, Oklahoma, 73034, United States

Location

Research Site 40001-386

Oklahoma City, Oklahoma, 73102, United States

Location

Research Site 40001-079

Oklahoma City, Oklahoma, 73120, United States

Location

Research Site 40001-027

Grants Pass, Oregon, 97527, United States

Location

Research Site 40001-337

Portland, Oregon, 97202, United States

Location

Research Site 40001-395

Hershey, Pennsylvania, 17033, United States

Location

Research Site 40001-327

Philadelphia, Pennsylvania, 19140, United States

Location

Research Site 40001-032

Columbia, South Carolina, 29204, United States

Location

Research Site 40001-025

Greenville, South Carolina, 29651, United States

Location

Research Site 40001-430

Rock Hill, South Carolina, 29732, United States

Location

Research Site 40001-073

Spartanburg, South Carolina, 29303, United States

Location

Research Site 40001-438

Dickson, Tennessee, 37055, United States

Location

Research Site 40001-414

Franklin, Tennessee, 37067, United States

Location

Research Site 40001-334

Allen, Texas, 75013, United States

Location

Research Site 40001-068

Amarillo, Texas, 79124, United States

Location

Research Site 40001-023

Dallas, Texas, 75230, United States

Location

Research Site 40001-028

Dallas, Texas, 75235, United States

Location

Research Site 40001-415

Dallas, Texas, 75246, United States

Location

Research Site 40001-304

DeSoto, Texas, 75115, United States

Location

Research Site 40001-418

Frisco, Texas, 75034, United States

Location

Research Site 40001-064

Houston, Texas, 77074, United States

Location

Research Site 40001-085

Houston, Texas, 77099, United States

Location

Research Site 40001-424

Kerrville, Texas, 78028, United States

Location

Research Site 40001-295

McKinney, Texas, 75069, United States

Location

Research Site 40001-304

Red Oak, Texas, 75154, United States

Location

Research Site 40001-377

San Antonio, Texas, 78258, United States

Location

Research Site 40001-335

Sugar Land, Texas, 77479, United States

Location

Research Site 40001-258

Murray, Utah, 84107, United States

Location

Research Site 40001-333

Pleasant View, Utah, 84404, United States

Location

Research Site 40001-340

Burke, Virginia, 22015, United States

Location

Research Site 40001-394

Williamsburg, Virginia, 23188, United States

Location

Research Site 40001-339

Greenfield, Wisconsin, 53228, United States

Location

Research Site 40001-433

La Crosse, Wisconsin, 54601, United States

Location

Research Site 40001-443

La Crosse, Wisconsin, 54601, United States

Location

Research Site 40054-035

Buenos Aires, B1878FNR, Argentina

Location

Research Site 40054-044

Buenos Aires, B1878FNR, Argentina

Location

Research Site 40054-034

Buenos Aires, B8000JRB, Argentina

Location

Research Site 40054-017

Buenos Aires, C1027AAP, Argentina

Location

Research Site 40054-008

Buenos Aires, C1426ABP, Argentina

Location

Research Site 40054-043

Buenos Aires, C14426ABP, Argentina

Location

Research Site 40054-015

Caba, C1121ABE, Argentina

Location

Research Site 40054-019

Mendoza, M5500AXR, Argentina

Location

Research Site 40054-016

Mendoza, M5500CBA, Argentina

Location

Research Site 40054-010

Mendoza, M5500CCG, Argentina

Location

Research Site 40054-028

Mendoza, M5501AAJ, Argentina

Location

Research Site 40054-032

Mendoza, M5501GCA, Argentina

Location

Research Site 40054-057

Mendoza, M5506BBH, Argentina

Location

Research Site 40054-024

San Miguel de Tucumán, C1425BEN, Argentina

Location

Research Site 40054-002

San Miguel de Tucumán, T4000CBC, Argentina

Location

Research Site 40054-020

San Miguel de Tucumán, T4000IAJ, Argentina

Location

Research Site 30043-013

Salzburg, 5020, Austria

Location

Research Site 40055-015

Belo Horizonte, Brazil

Location

Research Site 40055-007

Blumenau, 89030-101, Brazil

Location

Research Site 40055-011

Campo Largo, 83606-177, Brazil

Location

Research Site 40055-043

Curitiba, 80060-900, Brazil

Location

Research Site 40055-036

Curitiba, 80810-100, Brazil

Location

Research Site 40055-012

Porto Alegre, 90035-074, Brazil

Location

Research Site 40055-004

Porto Alegre, 90610-000, Brazil

Location

Research Site 40055-010

Porto Alegre, 91010-006, Brazil

Location

Research Site 40055-035

Rio de Janeiro, 22061-080, Brazil

Location

Research Site 40055-025

Salvador, 40060-325, Brazil

Location

Research Site 40055-005

Santo André, 09060-870, Brazil

Location

Research Site 40055-009

Santos, 11075-900, Brazil

Location

Research Site 40055-001

São Bernardo do Campo, 09715-090, Brazil

Location

Research Site 40011-004

Ajax, Ontario, L1S 2J5, Canada

Location

Research Site 40011-016

Ajax, Ontario, L1Z 0M1, Canada

Location

Research Site 40011-010

Burlington, Ontario, L7N, Canada

Location

Research Site 40011-014

Ottawa, Ontario, K1H 1E4, Canada

Location

Research Site 40011-005

Windsor, Ontario, N8X 2G1, Canada

Location

Research Site 40011-001

Windsor, Ontario, N8X 5A6, Canada

Location

Research Site 40011-018

Montreal, Quebec, H4A 3J1, Canada

Location

Research Site 40011-022

Québec, Quebec, G1G 3Y8, Canada

Location

Research Site 40011-020

Trois-Rivières, Quebec, G9A 4P3, Canada

Location

Research Site 40011-011

Vancouver, V5Z 1M9, Canada

Location

Research Site 40972-010

Ashkelon, 7830604, Israel

Location

Research Site 40972-008

Beersheba, 8410101, Israel

Location

Research Site 40972-005

Haifa, 3109601, Israel

Location

Research Site 40972-004

Haifa, 3436212, Israel

Location

Research Site 40972-001

Jerusalem, Israel

Location

Research Site 40972-009

Kfar Saba, 4428164, Israel

Location

Research Site 40972-002

Petah Tikva, 4941492, Israel

Location

Research Site 40972-011

Ramat Gan, 5262000, Israel

Location

Research Site 30060-006

Kampung Kelantan, Malaysia

Location

Research Site 40052-026

Chihuahua City, 31203, Mexico

Location

Research Site 40052-007

Guadalajara, 044100, Mexico

Location

Research Site 40052-028

Mexico City, 06700, Mexico

Location

Research Site 40052-012

San Juan del Río, 76800, Mexico

Location

Research Site 40048-001

Będzin, 42-500, Poland

Location

Research Site 40048-018

Bialystok, 15-044, Poland

Location

Research Site 40048-032

Bialystok, 15-430, Poland

Location

Research Site 40048-023

Gdansk, 80-214, Poland

Location

Research Site 40048-006

Giżycko, 11-500, Poland

Location

Research Site 40048-021

Katowice, 40-081, Poland

Location

Research Site 40048-002

Katowice, 40-365, Poland

Location

Research Site 40048-027

Krakow, 30-033, Poland

Location

Research Site 40048-033

Krakow, 31-011, Poland

Location

Research Site 40048-008

Krakow, 31-159, Poland

Location

Research Site 40048-040

Krakow, 31-864, Poland

Location

Research Site 40048-015

Lodz, 90-141, Poland

Location

Research Site 40048-009

Lodz, 90-302, Poland

Location

Research Site 40048-005

Lodz, 90-549, Poland

Location

Research Site 40048-022

Lublin, 20-089, Poland

Location

Research Site 40048-024

Maków Podhalański, 34-220, Poland

Location

Research Site 40048-031

Ostrowiec Świętokrzyski, 27-400, Poland

Location

Research Site 40048-010

Piaseczno, 05-500, Poland

Location

Research Site 40048-016

Poznan, 61-578, Poland

Location

Research Site 40048-039

Rzeszów, 35-205, Poland

Location

Research Site 40048-014

Skierniewice, 96-100, Poland

Location

Research Site 40048-012

Trzebnica, 55-100, Poland

Location

Research Site 40048-019

Wroclaw, 51-162, Poland

Location

Research Site 40787-365

Guaynabo, 00968, Puerto Rico

Location

Research Site 40787-390

Ponce, 00717, Puerto Rico

Location

Research Site 40787-388

San Juan, 00907, Puerto Rico

Location

Research Site 40787-383

San Juan, 00918, Puerto Rico

Location

Research Site 40787-405

San Juan, 00918, Puerto Rico

Location

Research Site 40787-360

San Juan, 00927, Puerto Rico

Location

Research Site 40787-345

Vega Baja, 00694, Puerto Rico

Location

Research Site 40040-004

Brasov, Brașov County, 50366, Romania

Location

Research Site 40040-006

Cluj-Napoca, Cluj, 400371, Romania

Location

Research Site 40040-002

Brasov, 500051, Romania

Location

Research Site 40040-009

Cluj-Napoca, 400162, Romania

Location

Research Site 40040-007

Cluj-Napoca, 400371, Romania

Location

Research Site 40040-001

Constanța, 900002, Romania

Location

Research Site 40040-010

Sângeorgiu de Mureş, 547365, Romania

Location

Research Site 40040-003

Timișoara, 300310, Romania

Location

Research Site 40027-013

Benoni, 1500, South Africa

Location

Research Site 40027-025

Cape Town, 7505, South Africa

Location

Research Site 40027-009

Cape Town, 7530, South Africa

Location

Research Site 40027-011

Cape Town, 7570, South Africa

Location

Research Site 40027-021

Cape Town, 7700, South Africa

Location

Research Site 30090-020

Durban, 4001, South Africa

Location

Research Site 40027-007

Durban, 7570, South Africa

Location

Research Site 40027-026

Johannesburg, 2193, South Africa

Location

Research Site 40027-005

KwaZulu, 4001, South Africa

Location

Research Site 40027-008

KwaZulu, 4092, South Africa

Location

Research Site 40027-020

KwaZulu, 4170, South Africa

Location

Research Site 40027-023

KwaZulu, 4301, South Africa

Location

Research Site 40027-027

KwaZulu, 4301, South Africa

Location

Research Site 40027-010

KwaZulu, 4450, South Africa

Location

Research Site 40027-006

Mpumalanga, 1050, South Africa

Location

Research Site 40027-004

Pretoria, 0002, South Africa

Location

Research Site 40027-019

Pretoria, 0204, South Africa

Location

Research Site 40027-018

Vereeniging, 1935, South Africa

Location

Research Site 40027-017

Welkom, 9460, South Africa

Location

Research Site 40082-003

Anyang-si, 14068, South Korea

Location

Research Site 30082-024

Bucheon-si, 14584, South Korea

Location

Research Site 40082-007

Busan, 48108, South Korea

Location

Research Site 40082-021

Gwangju, 61469, South Korea

Location

Research Site 40082-020

Incheon, 21565, South Korea

Location

Research Site 40082-006

Jeonju, 54907, South Korea

Location

Research Site 40082-019

Seoul, 04763, South Korea

Location

Research Site 40082-012

Seoul, 05030, South Korea

Location

Research Site 40082-008

Seoul, 06591, South Korea

Location

Research Site 40082-004

Seoul, 07061, South Korea

Location

Research Site 40082-011

Seoul, 08308, South Korea

Location

Research Site 40082-010

Suwon, 16499, South Korea

Location

Research Site 40886-001

Kaohsiung City, 807, Taiwan

Location

Research Site 40886-004

New Taipei City, 220, Taiwan

Location

Research Site 40886-006

New Taipei City, 23561, Taiwan

Location

Research Site 40886-005

Taichung, 40403, Taiwan

Location

Research Site 40886-007

Taichung, 40705, Taiwan

Location

Research Site 40886-010

Taipei, 100, Taiwan

Location

Research Site 40886-008

Taipei, 110, Taiwan

Location

Research Site 40866-003

Taipei, 11217, Taiwan

Location

Research Site 40886-009

Taipei, 11240, Taiwan

Location

Research Site 30066-004

Pathum Thani, 12120, Thailand

Location

Research Site 40090-002

Adana, 01240, Turkey (Türkiye)

Location

Research Site 40090-018

Ankara, 06230, Turkey (Türkiye)

Location

Research Site 40090-021

Ankara, 06230, Turkey (Türkiye)

Location

Research Site 40090-024

Ankara, 06230, Turkey (Türkiye)

Location

Research Site 40090-003

Ankara, 06560, Turkey (Türkiye)

Location

Research Site 40090-025

Ankara, 06560, Turkey (Türkiye)

Location

Research Site 40090-008

Ankara, 06620, Turkey (Türkiye)

Location

Research Site 40090-009

Ankara, 06930, Turkey (Türkiye)

Location

Research Site 40090-017

Antalya, 07400, Turkey (Türkiye)

Location

Research Site 40090-019

Bornova, 35100, Turkey (Türkiye)

Location

Research Site 40090-020

Istanbul, 34020, Turkey (Türkiye)

Location

Research Site 40090-026

Istanbul, 34750, Turkey (Türkiye)

Location

Research Site 40090-011

Istanbul, 34844, Turkey (Türkiye)

Location

Research Site 40090-012

Konak, 35110, Turkey (Türkiye)

Location

Research Site 40090-016

Merkez, 17020, Turkey (Türkiye)

Location

Research Site 40090-013

Mersin, 33110, Turkey (Türkiye)

Location

Research Site 40090-024

Pendik, Turkey (Türkiye)

Location

Research Site 40090-022

Tekirdağ, 59100, Turkey (Türkiye)

Location

Research Site 40380-002

Chernivtsi, 58001, Ukraine

Location

Research Site 40380-021

Chernivtsi, 58022, Ukraine

Location

Research Site 40380-009

Ivano-Frankivsk, 76008, Ukraine

Location

Research Site 40380-004

Ivano-Frankivsk, 76018, Ukraine

Location

Research Site 40380-017

Ivano-Frankivsk, 76018, Ukraine

Location

Research Site 40380-014

Ivano-Frankivsk, 76019, Ukraine

Location

Research Site 40380-019

Kyiv, 02002, Ukraine

Location

Research Site 40380-018

Kyiv, 03037, Ukraine

Location

Research Site 40380-007

Kyiv, 03038, Ukraine

Location

Research Site 40380-010

Kyiv, 03038, Ukraine

Location

Research Site 40380-012

Kyiv, 03038, Ukraine

Location

Research Site 40380-015

Kyiv, 03049, Ukraine

Location

Research Site 40380-011

Kyiv, 03057, Ukraine

Location

Research Site 40380-013

Kyiv, 03115, Ukraine

Location

Research Site 40380-016

Lutsk, 45634, Ukraine

Location

Research Site 40380-001

Ternopil, 46023, Ukraine

Location

Research Site 40380-003

Vinnytsia, 21001, Ukraine

Location

Research Site 40380-020

Vinnytsia, 21018, Ukraine

Location

Research Site 40380-008

Vinnytsia, 21029, Ukraine

Location

Research Site 40380-022

Vinnytsia, 21029, Ukraine

Location

Research Site 40380-005

Zhytomyr, 10002, Ukraine

Location

Research Site 40044-018

Bellshill, ML4 3NJ, United Kingdom

Location

Research Site 40044-021

Birmingham, B15 2SQ, United Kingdom

Location

Research Site 40044-077

Bollington, SK10 5JH, United Kingdom

Location

Research Site 40044-017

Chorley, PR7 7NA, United Kingdom

Location

Research Site 40044-022

Enfield, EN3 4GS, United Kingdom

Location

Research Site 40044-019

Liverpool, L22 0LG, United Kingdom

Location

Research Site 40044-084

London, E1 1 EQ, United Kingdom

Location

Research Site 40044-001

Manchester, BL9 0NJ, United Kingdom

Location

Research Site 40044-020

Manchester, M15 6SE, United Kingdom

Location

Research Site 40044-013

Manchester, M22 4DH, United Kingdom

Location

Research Site 40044-009

Manchester, M24 4DZ, United Kingdom

Location

Research Site 40044-036

Manchester, M27 0EW, United Kingdom

Location

Research Site 40044-006

Manchester, M33 4BR, United Kingdom

Location

Research Site 40044-024

Preston, PR2 9RB, United Kingdom

Location

Research Site 40044-026

Rochdale, OL11 4AU, United Kingdom

Location

Research Site 40044-008

Salford, M6 5WW, United Kingdom

Location

Research Site 40044-034

Stockport, SK8 5LL, United Kingdom

Location

Research Site 40044-078

Wythenshawe, M23 9QZ, United Kingdom

Location

MeSH Terms

Conditions

Pulmonary EosinophiliaAsthma

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesHypereosinophilic SyndromeEosinophiliaLeukocyte DisordersHematologic DiseasesHemic and Lymphatic DiseasesBronchial DiseasesLung Diseases, ObstructiveRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System Diseases

Study Officials

  • Mona Bafadhel, MD

    Guy's and St Thomas' NHS Foundation Trust

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 20, 2023

First Posted

February 28, 2023

Study Start

January 30, 2023

Primary Completion

September 1, 2025

Study Completion

December 1, 2025

Last Updated

September 5, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Locations